Navigation Links
Mylan Announces Clarinex(R) Settlement Agreement
Date:4/8/2009

PITTSBURGH, April 8 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced the settlement of all patent litigation relating to Desloratadine Tablets, 5 mg, the generic version of Schering- Plough's Clarinex(R) allergy medication. This litigation has been pending in the U.S. District Court of New Jersey since September 2006.

Pursuant to the settlement, Mylan will have the right to market Desloratadine Tablets, 5 mg, in the U.S. on July 1, 2012, or earlier in certain circumstances, provided that the U.S. Food and Drug Administration (FDA) approves Mylan's abbreviated new drug application (ANDA). Mylan's product may be the prescription form or an over-the-counter version, depending on the status of Clarinex at the time. Additional terms of the settlement are confidential, and the agreement is subject to review by the Department of Justice and the Federal Trade Commission.

Desloratadine Tablets, 5 mg, had U.S. sales of approximately $284 million for the 12 months ending Dec. 31, 2008, according to IMS Health.

This press release includes statements that constitute "forward-looking statements," including with regard to the settlement and marketing of the product. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: any legal or regulatory challenges to the settlement; strategies by competitors or other third parties to delay or prevent product introductions; risks inherent in legal and regulatory processes; and the other risks detailed in the company's periodic filings with t
'/>"/>

SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Announces Intention to Purchase Remaining Interest in Matrix Laboratories and Delist Matrix from Indian Stock Exchanges
2. Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
3. Mylans Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor
4. Mylan Announces Transition of Chief Financial Officer
5. Mylan Vice Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Opening Bell
6. Mylan Schedules Fourth Quarter Financial Results Conference Call and Live Webcast
7. Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER
8. Mylan Declares Quarterly Preferred Stock Dividend
9. Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
10. Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
11. U.S. Patent and Trademark Office Issues Mylans Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... On February 24, 2015, a Toledo, ... States District Court for the Northern District of Ohio ... as insurance companies Balboa, QBE, and Newport Management. (See ... 3:14-cv-152.) , The Plaintiff, a Ms. Dolores Gorsuch, says ... her to buy too much insurance at rates that ...
(Date:3/3/2015)... 2015 Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ... atypical antipsychotic medication continue to move forward in ... the South Carolina Supreme Court upheld a state ... Janssen Pharmaceuticals unit had deceptively marketed the medication ... Court’s February 25th decision characterized the company’s conduct ...
(Date:3/3/2015)... CA (PRWEB) March 03, 2015 Loma ... to whole health and well being, it will be ... machines across its campuses. , Over the past year, ... took part in creating dietary criteria, listening to vendors, ... for the entire organization. , Most recently, a ...
(Date:3/3/2015)... Today, Steve Weatherford, current New York Giants punter, ... the donation of their brains to science during a ... In an effort to raise awareness for the impact ... Rice and Weatherford spoke of their experiences on and ... health a priority to avoid the consequences of injuries ...
(Date:3/3/2015)... 03, 2015 Man, Woman & Student ... help find cures and ensure access to treatments for ... for patents and their families. Through this annual national ... the fight for a world without blood cancers. The ... in the country, to be announced this summer. To ...
Breaking Medicine News(10 mins):Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3
... , ZURICH , Jan. 25 The Starr ... to two humanitarian organizations providing critical relief in Haiti . ... support efforts to deliver much-needed medical care, clean water and sanitation ... $750,000 grant to Partners in Health (PIH) to help ...
... , , WASHINGTON ... an unsafe, counterfeit version of the weight-loss drug Alli sold over ... tests showed that the counterfeit Alli has a different active ingredient, ... counterfeit Alli may be taking three times the usual ...
... shows that acyclovir, a commonly prescribed drug used to suppress ... by people with both viruses. The study, conducted ... by the New England Journal of Medicine in ... print edition Feb. 4. The largest risk group ...
... ... Orange Israel Telecommunications have announced today that they are aiding humanitarian efforts in ... be the first of three stages of establishing the orphanage which is expected ... be providing fresh, running drinking water, an electric generator, tents and primary medical ...
... WASHINGTON , Jan. 25 In an effort ... is currently accepting applications for its 2010 Advocates in Disability Award, ... 26 in the Washington, DC Metropolitan area who is ... on their current and previous work that impacts people with disabilities, ...
... , NEW YORK , ... of the 25 largest PR firms ( http://www.5wpr.net/ ) in the U.S., today ... its versatile roster of fashion and lifestyle clients. Launched in 2002, the luxury ... lifestyle products using proprietary natural frequency technology. , " Philip Stein is ...
Cached Medicine News:Health News:Starr International Foundation Gives $1 Million To Earthquake Relief Effort In Haiti 2Health News:FDA CONSUMER HEALTH INFORMATION: FDA Warns Consumers About Unsafe Counterfeit Alli 2Health News:Control of herpes symptoms does not reduce HIV transmission, international study found 2Health News:Israel Flying Aid, Orange Israel Create Haiti Orphanage, Provide Humanitarian Aid 2Health News:Israel Flying Aid, Orange Israel Create Haiti Orphanage, Provide Humanitarian Aid 3Health News:Israel Flying Aid, Orange Israel Create Haiti Orphanage, Provide Humanitarian Aid 4Health News:DC Nonprofit Searches for Next Generation of Disability Advocates 2Health News:5W Public Relations Adds Philip Stein Watches to Its Fashion & Lifestyle Client Roster 2Health News:5W Public Relations Adds Philip Stein Watches to Its Fashion & Lifestyle Client Roster 3
(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ... POC Diagnostics Market 2015-2019" report to their offering. ... POC Diagnostics market to grow at a CAGR of ... POC diagnostics are IVD devices and tools used for ... The use of these devices helps in the rapid ...
(Date:3/3/2015)... , March 3, 2015  Michigan brothers Dominique ... condition called arrhythmogenic right ventricular dysplasia, or ARVD, a disease ... of sudden death among young athletes. In 2007, ... a basketball game. They later tested Dominique and found his ... a February 19, 2015 story in The Ann Arbor ...
(Date:3/3/2015)... , March 3, 2015  Web Industries, ... manufacturing services in the Medical Device, Advanced Composites, ... been named a 3M Medical Specialties Preferred Converter ... status will allow companies to streamline their supply ... of contact for 3M materials, intermediate converting services, ...
Breaking Medicine Technology:Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3Web Industries Receives 3M Preferred Converter Status 2
Aire-Cuf® tracheostomy tubes are ideal for short-term to medium-term ventilator support....
... in both neonatal and pediatric sizes., ,The ... it has a cuff. When completely deflated, it ... , ,TTS™ (tight-to-shaft) tubes have the profile ... a cuff, if and when needed. , ...
... TTS™ tracheostomy tubes are available in both neonatal ... like an uncuffed tube, but it has a ... the shaft of the tube. , ,TTS™ ... tube with the insurance of a cuff, if ...
... tracheostomy tubes are intended for ... length fixed neck flange tube ... ,Adjustable neck flange Hyperflex™ tracheostomy ... both horizontal and vertical shaft ...
Medicine Products: